| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/20/2005 | WO2004099525A3 Reaction module for biological analysis |
| 01/20/2005 | WO2004099430A3 Substrate in the form of a ligate carrier |
| 01/20/2005 | WO2004097425A9 Method of selecting chemokine antagonists and agonists |
| 01/20/2005 | WO2004094989A3 Methods of host cell protein analysis |
| 01/20/2005 | WO2004093845A3 Ligand-coupled initiator polymers and methods of use |
| 01/20/2005 | WO2004092716B1 Method and apparatus for inspecting a substrate using a plurality of inspection wavelength regimes |
| 01/20/2005 | WO2004090551A3 Secreted polypeptide species associated with cardiovascular disorders |
| 01/20/2005 | WO2004090031A8 Methods of selecting and developing a particulate material |
| 01/20/2005 | WO2004088562A8 Methods of specifying or identifying particulate material |
| 01/20/2005 | WO2004087758A3 Il 13 receptor alpha 2 antibody and methods of use |
| 01/20/2005 | WO2004087308A8 Method of synthesis and testing of combinatorial libraries using microcapsules |
| 01/20/2005 | WO2004087259A3 Pharmaceutical composition effective in treatment of mechanical allodynia, screening method of potential compound as said pharmaceutical composition, abd inspection method of mechanical allodynia |
| 01/20/2005 | WO2004086047A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a1 (adora1) |
| 01/20/2005 | WO2004086021A3 Apparatus for analyzing mixtures of gases |
| 01/20/2005 | WO2004085673A3 Compositions and methods of using hexokinase v |
| 01/20/2005 | WO2004082608A3 Ligands for tgf-beta binding proteins and uses thereof |
| 01/20/2005 | WO2004081186A8 Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof |
| 01/20/2005 | WO2004079368A3 Markers for colorectal cancer |
| 01/20/2005 | WO2004079367A8 Bioarray |
| 01/20/2005 | WO2004078131A3 Evaluating effects of exposure conditions on drug samples over time |
| 01/20/2005 | WO2004076648A9 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 01/20/2005 | WO2004075818A3 Stress specific molecular response in neurons |
| 01/20/2005 | WO2004071394A3 Diagnostics and therapeutics for diseases associated with hm74 |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2004066940A3 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 01/20/2005 | WO2004064742A9 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 01/20/2005 | WO2004057336A3 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer |
| 01/20/2005 | WO2004048925A3 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 01/20/2005 | WO2004042070A9 Electrical detection of dna hybridization and specific binding events |
| 01/20/2005 | WO2004038408A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 01/20/2005 | WO2004038040A3 Enzyme array and assay |
| 01/20/2005 | WO2004013636A3 Differential labeling for quantitative analysis of complex protein mixtures by trifunctional synthetic peptide based reagents with iodoacetamido groups |
| 01/20/2005 | WO2004005884B1 Method and apparatus for molecular mechanics analysis of molecular systems |
| 01/20/2005 | WO2003103017A3 Method and system of determining chamber seasoning condition by optical emission |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003057155A3 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 01/20/2005 | WO2003035848A9 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 01/20/2005 | WO2003026494A3 Galectins-1-and-4 in tumor development |
| 01/20/2005 | US20050015824 Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| 01/20/2005 | US20050015823 Screening methods employing fish model assessment of vision |
| 01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
| 01/20/2005 | US20050015211 System, method, and program for estimating gene expression state, and recording medium therefor |
| 01/20/2005 | US20050015207 Method and apparatus for object based biological information, manipulation and management |
| 01/20/2005 | US20050015001 Transducer biosensor for measurement blood physical properties such as coagulation, platelets, blood disorders |
| 01/20/2005 | US20050015000 Method and device for analysing a liquid |
| 01/20/2005 | US20050014935 Chimeric protein comprising amadoriase activity for use in diagnosis and prognosis of diabetic pathologies |
| 01/20/2005 | US20050014931 A monoclonal antibody or an antigen-binding fragment thereof that specifically binds the capsular polysaccharide of Streptococcus pneumoniae serotype PPS 3; heavy chain amino acid sequence as well as DNA encoding it; complementary determining regions; pneumonia; passive immunizations; diagnosis/medical/ |
| 01/20/2005 | US20050014834 Selective anesthetic agents and methods of identifying the same |
| 01/20/2005 | US20050014821 Compounds and methods for treating neurodegenerative disorders |
| 01/20/2005 | US20050014785 Treatment of radiation disorders |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014718 Tumor specific oligosaccharide sequences and use thereof |
| 01/20/2005 | US20050014710 Compositions and methods relating to prostate specific genes and proteins |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014692 Isolate nucleic acids; intensify stimulated insulin elimination; antidiabetic agents |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014682 Cell-free assay for insulin signaling |
| 01/20/2005 | US20050014680 Administering nuclear factor of activated T-cell agonist |
| 01/20/2005 | US20050014647 For plants; using alanine, ammonium hydroxide, asparagine and, or oxopropionic acid; measurement of acetolactic acid; calibration |
| 01/20/2005 | US20050014292 Protein arrays for high-throughput screening |
| 01/20/2005 | US20050014291 Assay method using biochemical analysis units and cleaning apparatus for the same |
| 01/20/2005 | US20050014290 Binding proteins as biosensors |
| 01/20/2005 | US20050014289 Stable compositions for measuring human natriuretic peptides |
| 01/20/2005 | US20050014288 Motion induced electrical field stimulation |
| 01/20/2005 | US20050014287 Stable calibrators or controls for measuring human natriuretic peptides |
| 01/20/2005 | US20050014286 Bio-assay substrate, bio-assay apparatus, and reading apparatus |
| 01/20/2005 | US20050014284 Using hollow probe with capacity of eduction and discharge to combine liquid contents of container; detecting high density lipoprotein present in liquids; automated immunochemical analysis |
| 01/20/2005 | US20050014283 Fine particles containing rare earth element and fluorescent probe using the same |
| 01/20/2005 | US20050014281 Apparatus and method for detecting undesired residues in a sample |
| 01/20/2005 | US20050014279 Method of analysis of amine by mass spectrometry |
| 01/20/2005 | US20050014278 Acid-labile isotope-coded extractant (ALICE) and its use in quantitative mass spectrometric analysis of protein mixtures |
| 01/20/2005 | US20050014277 Method for identification and/or diagnosis of REM sleep loss from blood samples |
| 01/20/2005 | US20050014276 Method for quatitative determination of dicarbonyl compounds |
| 01/20/2005 | US20050014275 Determining concentration of hemoglobin in blood sample; erythrocyte membrane removal; point of care testing |
| 01/20/2005 | US20050014268 Poly-(ADP-ribose) polymerase (PARP); assessing agronomical fitness of plant in vitro via seed yield; subjecting to stress then measuring electron flow in mitochondrial electron transport chain |
| 01/20/2005 | US20050014261 Chimaeric phages |
| 01/20/2005 | US20050014249 Multicompartment bioassay for use in detection and quantification of analytes in the blood or other body fluids; immunoassay |
| 01/20/2005 | US20050014246 Apparatus comprising immobilized biopolymers for use in diagnostic tools in monitoring molecular interactions ; bioreactor; high throughput assay |
| 01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014224 GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014217 Exposing liver tissue with enhanced cytochrome p450 expression to stimulus and using imaging analysis to detect cytotoxic features/damages generated after exposure to stimulus |
| 01/20/2005 | US20050014216 Predicting hepatotoxicity using cell based assays |
| 01/20/2005 | US20050014213 Method of colorimetry and reagent for use therein |
| 01/20/2005 | US20050014211 Functional vitamin D derivatives and method of determining 25-hydroxy- and 1alpha, 25-dihydroxy vitamin D |
| 01/20/2005 | US20050014210 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/20/2005 | US20050014209 Novel prostate cancer cell lines |
| 01/20/2005 | US20050014208 Using presence of tumor marker proteins as diagnostic and/or prognostic tools in diagnosis and treatment of cell proliferative disorders; immunodiagnostics |
| 01/20/2005 | US20050014205 Diagnostic assay for measuring a cell mediated immune response |
| 01/20/2005 | US20050014204 immunologically determining the quantity of hydrophobin having the formula X2-38 C X5-9 C C X11-39 C X8-23 C X5-9 C C X6-18 C X2-13 where X is an aminoacid other than cysteine, and C is cysteine from the beverage using an immunological reaction; especially for beer |
| 01/20/2005 | US20050014203 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 01/20/2005 | US20050014202 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| 01/20/2005 | US20050014201 Multicompartment apparatus for monitoring morphology and physiological functions of viable cells; biosensors |
| 01/20/2005 | US20050014200 Using autoantibodies of angiotensin receptor as diagnostic/prognostic indicator of psychological disorders; immunodiagnostics |
| 01/20/2005 | US20050014198 Using urotensin concentration as diagnostic/prognostic indicator of cardiovascular disorders; immunoassay |
| 01/20/2005 | US20050014197 Immobilization; chelation; incubation; hybridization; chromatography; mass spectrometry; proteomics; kits |
| 01/20/2005 | US20050014196 Prion protein binding materials and methods of use |